10-K Filing
Filing Information
| Form Type | 10-K |
| Accession Number | 0001564590-16-013587 |
| Period End Date | 20151231 |
| Filing Date | 20160226 |
| Fiscal Year | 2015 |
| Fiscal Period | FY |
| XBRL Instance | dva-20151231.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
91 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Accounts receivable, allowance |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$242.67M | USD | Point-in-time |
| Accounts receivable, allowance |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$264.14M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$946.25M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$1.50B | USD | Point-in-time |
| Preferred stock, par value |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$965.24M | USD | Point-in-time |
| Preferred stock, par value |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$533.75M | USD | Point-in-time |
| Preferred stock, shares authorized |
PreferredStockSharesAuthorized
|
5.00M | shares | Point-in-time |
| Short-term investments |
MarketableSecuritiesCurrent
|
$337.40M | USD | Point-in-time |
| Short-term investments |
MarketableSecuritiesCurrent
|
$408.08M | USD | Point-in-time |
| Preferred stock, shares authorized |
PreferredStockSharesAuthorized
|
5.00M | shares | Point-in-time |
| Preferred stock, issued |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Preferred stock, issued |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Accounts receivable, less allowance of $264,144 and $242,674 |
AccountsReceivableNetCurrent
|
$1.53B | USD | Point-in-time |
| Accounts receivable, less allowance of $264,144 and $242,674 |
AccountsReceivableNetCurrent
|
$1.72B | USD | Point-in-time |
| Inventories |
InventoryNet
|
$136.08M | USD | Point-in-time |
| Common stock, par value |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Inventories |
InventoryNet
|
$185.57M | USD | Point-in-time |
| Common stock, par value |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
450.00M | shares | Point-in-time |
| Other receivables |
OtherReceivablesNetCurrent
|
$400.92M | USD | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
450.00M | shares | Point-in-time |
| Other receivables |
OtherReceivablesNetCurrent
|
$435.88M | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$190.32M | USD | Point-in-time |
| Common stock, shares issued |
CommonStockSharesIssued
|
215.64M | shares | Point-in-time |
| Common stock, shares issued |
CommonStockSharesIssued
|
217.12M | shares | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$186.84M | USD | Point-in-time |
| Income tax receivable |
IncomeTaxesReceivable
|
$60.07M | USD | Point-in-time |
| Income tax receivable |
IncomeTaxesReceivable
|
$83.84M | USD | Point-in-time |
| Common stock, shares outstanding |
CommonStockSharesOutstanding
|
209.75M | shares | Point-in-time |
| Common stock, shares outstanding |
CommonStockSharesOutstanding
|
215.64M | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$3.64B | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$4.50B | USD | Point-in-time |
| Treasury stock, shares |
TreasuryStockShares
|
7.37M | shares | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$2.79B | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$2.47B | USD | Point-in-time |
| Intangible assets, net |
FiniteLivedIntangibleAssetsNet
|
$1.86B | USD | Point-in-time |
| Intangible assets, net |
FiniteLivedIntangibleAssetsNet
|
$1.69B | USD | Point-in-time |
| Equity investments |
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
$73.37M | USD | Point-in-time |
| Equity investments |
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
$65.64M | USD | Point-in-time |
| Long-term investments |
LongTermInvestments
|
$94.12M | USD | Point-in-time |
| Long-term investments |
LongTermInvestments
|
$89.39M | USD | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
$77.00M | USD | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
$73.56M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$9.42B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$9.21B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$9.29B | USD | Point-in-time |
| Total assets |
Assets
|
$18.51B | USD | Point-in-time |
| Total assets |
Assets
|
$17.62B | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$445.45M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$513.95M | USD | Point-in-time |
| Other liabilities |
OtherLiabilitiesCurrent
|
$682.12M | USD | Point-in-time |
| Other liabilities |
OtherLiabilitiesCurrent
|
$510.22M | USD | Point-in-time |
| Accrued compensation and benefits |
EmployeeRelatedLiabilitiesCurrent
|
$741.93M | USD | Point-in-time |
| Accrued compensation and benefits |
EmployeeRelatedLiabilitiesCurrent
|
$698.48M | USD | Point-in-time |
| Medical payables |
MedicalExpensePayable
|
$332.10M | USD | Point-in-time |
| Medical payables |
MedicalExpensePayable
|
$314.35M | USD | Point-in-time |
| Current portion of long-term debt |
LongTermDebtAndCapitalLeaseObligationsCurrent
|
$120.15M | USD | Point-in-time |
| Current portion of long-term debt |
LongTermDebtAndCapitalLeaseObligationsCurrent
|
$129.04M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$2.40B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$2.09B | USD | Point-in-time |
| Long-term debt |
LongTermDebtAndCapitalLeaseObligations
|
$8.30B | USD | Point-in-time |
| Long-term debt |
LongTermDebtAndCapitalLeaseObligations
|
$9.00B | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$439.23M | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$389.81M | USD | Point-in-time |
| Deferred income taxes |
DeferredTaxLiabilitiesNoncurrent
|
$726.96M | USD | Point-in-time |
| Deferred income taxes |
DeferredTaxLiabilitiesNoncurrent
|
$650.08M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$12.57B | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$11.43B | USD | Point-in-time |
| Noncontrolling interests subject to put provisions |
RedeemableNoncontrollingInterestEquityCarryingAmount
|
$829.97M | USD | Point-in-time |
| Noncontrolling interests subject to put provisions |
RedeemableNoncontrollingInterestEquityCarryingAmount
|
$864.07M | USD | Point-in-time |
| Preferred stock ($0.001 par value, 5,000,000 shares authorized; none issued) |
PreferredStockValue
|
- | USD | Point-in-time |
| Preferred stock ($0.001 par value, 5,000,000 shares authorized; none issued) |
PreferredStockValue
|
- | USD | Point-in-time |
| Common stock ($0.001 par value, 450,000,000 shares authorized; 217,120,346 and 215,640,968 shares issued and 209,754,247 and 215,640,968 shares outstanding, respectively) |
CommonStockValue
|
$216.00K | USD | Point-in-time |
| Common stock ($0.001 par value, 450,000,000 shares authorized; 217,120,346 and 215,640,968 shares issued and 209,754,247 and 215,640,968 shares outstanding, respectively) |
CommonStockValue
|
$217.00K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$1.11B | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$1.12B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$4.09B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$4.36B | USD | Point-in-time |
| Treasury stock (7,366,099 shares) |
TreasuryStockValue
|
$544.77M | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-25.02M | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-59.83M | USD | Point-in-time |
| Total DaVita HealthCare Partners Inc. shareholders' equity |
StockholdersEquity
|
$4.87B | USD | Point-in-time |
| Total DaVita HealthCare Partners Inc. shareholders' equity |
StockholdersEquity
|
$5.17B | USD | Point-in-time |
| Noncontrolling interests not subject to put provisions |
MinorityInterest
|
$189.80M | USD | Point-in-time |
| Noncontrolling interests not subject to put provisions |
MinorityInterest
|
$213.39M | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.08B | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.36B | USD | Point-in-time |
| Total liabilities and equity |
LiabilitiesAndStockholdersEquity
|
$18.51B | USD | Point-in-time |
| Total liabilities and equity |
LiabilitiesAndStockholdersEquity
|
$17.62B | USD | Point-in-time |
Income Statement
169 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Patient service revenues |
HealthCareOrganizationPatientServiceRevenue
|
$3.53B | USD | 1 Quarter |
| Patient service revenues |
HealthCareOrganizationPatientServiceRevenue
|
$3.04B | USD | 1 Quarter |
| Patient service revenues |
HealthCareOrganizationPatientServiceRevenue
|
$3.17B | USD | 1 Quarter |
| Patient service revenues |
HealthCareOrganizationPatientServiceRevenue
|
$9.48B | USD | Annual |
| Patient service revenues |
HealthCareOrganizationPatientServiceRevenue
|
$3.29B | USD | 1 Quarter |
| Patient service revenues |
HealthCareOrganizationPatientServiceRevenue
|
$3.53B | USD | 1 Quarter |
| Patient service revenues |
HealthCareOrganizationPatientServiceRevenue
|
$3.33B | USD | 1 Quarter |
| Patient service revenues |
HealthCareOrganizationPatientServiceRevenue
|
$8.31B | USD | Annual |
| Patient service revenues |
HealthCareOrganizationPatientServiceRevenue
|
$3.43B | USD | 1 Quarter |
| Patient service revenues |
HealthCareOrganizationPatientServiceRevenue
|
$3.25B | USD | 1 Quarter |
| Patient service revenues |
HealthCareOrganizationPatientServiceRevenue
|
$8.87B | USD | Annual |
| Less: Provision for uncollectible accounts |
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
|
$293.55M | USD | Annual |
| Less: Provision for uncollectible accounts |
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
|
$427.86M | USD | Annual |
| Less: Provision for uncollectible accounts |
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
|
$366.88M | USD | Annual |
| Net patient service revenues |
HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
|
$9.05B | USD | Annual |
| Net patient service revenues |
HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
|
$8.01B | USD | Annual |
| Net patient service revenues |
HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
|
$8.50B | USD | Annual |
| Capitated revenues |
HealthCareOrganizationCapitationRevenue
|
$2.99B | USD | Annual |
| Capitated revenues |
HealthCareOrganizationCapitationRevenue
|
$3.26B | USD | Annual |
| Capitated revenues |
HealthCareOrganizationCapitationRevenue
|
$3.51B | USD | Annual |
| Other revenues |
HealthCareOrganizationOtherRevenue
|
$1.03B | USD | Annual |
| Other revenues |
HealthCareOrganizationOtherRevenue
|
$1.22B | USD | Annual |
| Other revenues |
HealthCareOrganizationOtherRevenue
|
$763.09M | USD | Annual |
| Total net revenues |
HealthCareOrganizationRevenue
|
$12.80B | USD | Annual |
| Total net revenues |
HealthCareOrganizationRevenue
|
$11.76B | USD | Annual |
| Total net revenues |
HealthCareOrganizationRevenue
|
$13.78B | USD | Annual |
| Patient care costs and other costs |
PatientCareCosts
|
$9.12B | USD | Annual |
| Patient care costs and other costs |
PatientCareCosts
|
$8.20B | USD | Annual |
| Patient care costs and other costs |
PatientCareCosts
|
$9.82B | USD | Annual |
| General and administrative |
GeneralAndAdministrativeExpense
|
$1.18B | USD | Annual |
| General and administrative |
GeneralAndAdministrativeExpense
|
$1.45B | USD | Annual |
| General and administrative |
GeneralAndAdministrativeExpense
|
$1.26B | USD | Annual |
| Depreciation and amortization |
DepreciationAndAmortization
|
$528.74M | USD | Annual |
| Depreciation and amortization |
DepreciationAndAmortization
|
$638.02M | USD | Annual |
| Depreciation and amortization |
DepreciationAndAmortization
|
$590.93M | USD | Annual |
| Provision for uncollectible accounts |
ProvisionForDoubtfulAccounts
|
$9.24M | USD | Annual |
| Provision for uncollectible accounts |
ProvisionForDoubtfulAccounts
|
$14.45M | USD | Annual |
| Provision for uncollectible accounts |
ProvisionForDoubtfulAccounts
|
$4.85M | USD | Annual |
| Equity investment income |
IncomeLossFromEquityMethodInvestments
|
$18.32M | USD | Annual |
| Equity investment income |
IncomeLossFromEquityMethodInvestments
|
$23.23M | USD | Annual |
| Equity investment income |
IncomeLossFromEquityMethodInvestments
|
$34.56M | USD | Annual |
| Goodwill and other intangible asset impairment charges |
GoodwillAndIntangibleAssetImpairment
|
$210.23M | USD | Annual |
| Settlement charge and loss contingency accrual |
LossContingencyLossInPeriod
|
$495.00M | USD | Annual |
| Settlement charge and loss contingency accrual |
LossContingencyLossInPeriod
|
$397.00M | USD | Annual |
| Settlement charge and loss contingency accrual |
LossContingencyLossInPeriod
|
$17.00M | USD | Annual |
| Contingent earn-out obligation adjustment |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$-56.98M | USD | Annual |
| Total operating expenses and charges |
CostsAndExpenses
|
$10.21B | USD | Annual |
| Total operating expenses and charges |
CostsAndExpenses
|
$12.61B | USD | Annual |
| Total operating expenses and charges |
CostsAndExpenses
|
$10.98B | USD | Annual |
| Operating income |
OperatingIncomeLoss
|
$480.55M | USD | 1 Quarter |
| Operating income |
OperatingIncomeLoss
|
$437.54M | USD | 1 Quarter |
| Operating income |
OperatingIncomeLoss
|
$1.17B | USD | Annual |
| Operating income |
OperatingIncomeLoss
|
$441.23M | USD | 1 Quarter |
| Operating income |
OperatingIncomeLoss
|
$1.55B | USD | Annual |
| Operating income |
OperatingIncomeLoss
|
$-64.16M | USD | 1 Quarter |
| Operating income |
OperatingIncomeLoss
|
$484.30M | USD | 1 Quarter |
| Operating income |
OperatingIncomeLoss
|
$1.82B | USD | Annual |
| Operating income |
OperatingIncomeLoss
|
$244.94M | USD | 1 Quarter |
| Operating income |
OperatingIncomeLoss
|
$452.08M | USD | 1 Quarter |
| Operating income |
OperatingIncomeLoss
|
$509.37M | USD | 1 Quarter |
| Debt expense |
InterestAndDebtExpense
|
$408.38M | USD | Annual |
| Debt expense |
InterestAndDebtExpense
|
$429.94M | USD | Annual |
| Debt expense |
InterestAndDebtExpense
|
$410.29M | USD | Annual |
| Debt redemption and refinancing charges |
DebtRefinancingCharge
|
$97.55M | USD | Annual |
| Debt redemption and refinancing charges |
DebtRefinancingCharge
|
$48.07M | USD | Annual |
| Other income, net |
OtherNonoperatingIncomeExpense
|
$4.79M | USD | Annual |
| Other income, net |
OtherNonoperatingIncomeExpense
|
$8.89M | USD | Annual |
| Other income, net |
OtherNonoperatingIncomeExpense
|
$2.37M | USD | Annual |
| Income from continuing operations before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$354.37M | USD | 1 Quarter |
| Income from continuing operations before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$-162.08M | USD | 1 Quarter |
| Income from continuing operations before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$723.14M | USD | Annual |
| Income from continuing operations before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$336.41M | USD | 1 Quarter |
| Income from continuing operations before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$282.31M | USD | 1 Quarter |
| Income from continuing operations before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$1.31B | USD | Annual |
| Income from continuing operations before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$1.12B | USD | Annual |
| Income from continuing operations before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$408.37M | USD | 1 Quarter |
| Income from continuing operations before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$146.31M | USD | 1 Quarter |
| Income from continuing operations before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$336.59M | USD | 1 Quarter |
| Income from continuing operations before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$330.54M | USD | 1 Quarter |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$295.73M | USD | Annual |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$381.01M | USD | Annual |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$446.34M | USD | Annual |
| Income from continuing operations |
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
$743.97M | USD | Annual |
| Income from continuing operations |
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
$427.41M | USD | Annual |
| Income from continuing operations |
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
$863.33M | USD | Annual |
| Loss from operations of discontinued operations, net of tax |
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
|
$-139.00K | USD | Annual |
| Gain on disposal of discontinued operations, net of tax |
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
|
$13.38M | USD | Annual |
| Net income |
ProfitLoss
|
$863.33M | USD | Annual |
| Net income |
ProfitLoss
|
$427.41M | USD | Annual |
| Net income |
ProfitLoss
|
$757.20M | USD | Annual |
| Less: Net income attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$157.68M | USD | Annual |
| Less: Net income attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$140.22M | USD | Annual |
| Less: Net income attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$123.75M | USD | Annual |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$-6.00M | USD | 1 Quarter |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$633.45M | USD | Annual |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$-110.62M | USD | 1 Quarter |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$215.87M | USD | 1 Quarter |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$170.48M | USD | 1 Quarter |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$147.68M | USD | 1 Quarter |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$183.29M | USD | 1 Quarter |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$723.11M | USD | Annual |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$208.02M | USD | 1 Quarter |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$269.73M | USD | Annual |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$184.12M | USD | 1 Quarter |
| Basic income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerBasicShare
|
$0.98 | USD | 1 Quarter |
| Basic income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerBasicShare
|
$1.02 | USD | 1 Quarter |
| Basic income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerBasicShare
|
$1.27 | USD | Annual |
| Basic income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerBasicShare
|
$0.87 | USD | 1 Quarter |
| Basic income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerBasicShare
|
$-0.03 | USD | 1 Quarter |
| Basic income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerBasicShare
|
$0.70 | USD | 1 Quarter |
| Basic income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerBasicShare
|
$3.41 | USD | Annual |
| Basic income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerBasicShare
|
$0.87 | USD | 1 Quarter |
| Basic income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerBasicShare
|
$-0.52 | USD | 1 Quarter |
| Basic income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerBasicShare
|
$0.80 | USD | 1 Quarter |
| Basic income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerBasicShare
|
$2.95 | USD | Annual |
| Basic net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareBasic
|
$-0.03 | USD | 1 Quarter |
| Basic net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareBasic
|
$0.98 | USD | 1 Quarter |
| Basic net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareBasic
|
$1.02 | USD | 1 Quarter |
| Basic net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareBasic
|
$0.70 | USD | 1 Quarter |
| Basic net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareBasic
|
$0.87 | USD | 1 Quarter |
| Basic net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareBasic
|
$0.80 | USD | 1 Quarter |
| Basic net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareBasic
|
$-0.52 | USD | 1 Quarter |
| Basic net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareBasic
|
$0.87 | USD | 1 Quarter |
| Basic net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareBasic
|
$1.27 | USD | Annual |
| Basic net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareBasic
|
$3.41 | USD | Annual |
| Basic net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareBasic
|
$3.02 | USD | Annual |
| Diluted income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerDilutedShare
|
$1.25 | USD | Annual |
| Diluted income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerDilutedShare
|
$1.00 | USD | 1 Quarter |
| Diluted income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerDilutedShare
|
$0.68 | USD | 1 Quarter |
| Diluted income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerDilutedShare
|
$0.78 | USD | 1 Quarter |
| Diluted income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerDilutedShare
|
$0.85 | USD | 1 Quarter |
| Diluted income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerDilutedShare
|
$3.33 | USD | Annual |
| Diluted income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerDilutedShare
|
$-0.52 | USD | 1 Quarter |
| Diluted income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerDilutedShare
|
$0.85 | USD | 1 Quarter |
| Diluted income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerDilutedShare
|
$2.89 | USD | Annual |
| Diluted income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerDilutedShare
|
$-0.03 | USD | 1 Quarter |
| Diluted income from continuing operations per share attributable to DaVita HealthCare Partners Inc. |
IncomeLossFromContinuingOperationsPerDilutedShare
|
$0.96 | USD | 1 Quarter |
| Diluted net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareDiluted
|
$0.78 | USD | 1 Quarter |
| Diluted net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareDiluted
|
$0.85 | USD | 1 Quarter |
| Diluted net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareDiluted
|
$-0.52 | USD | 1 Quarter |
| Diluted net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareDiluted
|
$0.85 | USD | 1 Quarter |
| Diluted net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareDiluted
|
$1.00 | USD | 1 Quarter |
| Diluted net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareDiluted
|
$0.96 | USD | 1 Quarter |
| Diluted net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareDiluted
|
$1.25 | USD | Annual |
| Diluted net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareDiluted
|
$2.95 | USD | Annual |
| Diluted net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareDiluted
|
$3.33 | USD | Annual |
| Diluted net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareDiluted
|
$0.68 | USD | 1 Quarter |
| Diluted net income per share attributable to DaVita HealthCare Partners Inc. |
EarningsPerShareDiluted
|
$-0.03 | USD | 1 Quarter |
| Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
212.30M | shares | Annual |
| Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
211.87M | shares | Annual |
| Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
209.94M | shares | Annual |
| Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
216.25M | shares | Annual |
| Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
214.76M | shares | Annual |
| Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
216.93M | shares | Annual |
| Income from continuing operations |
IncomeLossFromContinuingOperations
|
$269.73M | USD | Annual |
| Income from continuing operations |
IncomeLossFromContinuingOperations
|
$723.11M | USD | Annual |
| Income from continuing operations |
IncomeLossFromContinuingOperations
|
$620.20M | USD | Annual |
| Discontinued operations |
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
$13.25M | USD | Annual |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$-6.00M | USD | 1 Quarter |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$633.45M | USD | Annual |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$-110.62M | USD | 1 Quarter |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$215.87M | USD | 1 Quarter |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$170.48M | USD | 1 Quarter |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$147.68M | USD | 1 Quarter |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$183.29M | USD | 1 Quarter |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$723.11M | USD | Annual |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$208.02M | USD | 1 Quarter |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$269.73M | USD | Annual |
| Net income attributable to DaVita HealthCare Partners Inc. |
NetIncomeLoss
|
$184.12M | USD | 1 Quarter |
Cash Flow Statement
138 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income |
ProfitLoss
|
$863.33M | USD | Annual |
| Net income |
ProfitLoss
|
$427.41M | USD | Annual |
| Net income |
ProfitLoss
|
$757.20M | USD | Annual |
| Settlement charge and loss contingency accrual |
LossContingencyLossInPeriod
|
$495.00M | USD | Annual |
| Settlement charge and loss contingency accrual |
LossContingencyLossInPeriod
|
$397.00M | USD | Annual |
| Settlement charge and loss contingency accrual |
LossContingencyLossInPeriod
|
$17.00M | USD | Annual |
| Depreciation and amortization |
AdjustmentDepreciationAndAmortization
|
$528.12M | USD | Annual |
| Depreciation and amortization |
AdjustmentDepreciationAndAmortization
|
$590.93M | USD | Annual |
| Depreciation and amortization |
AdjustmentDepreciationAndAmortization
|
$638.02M | USD | Annual |
| Goodwill and other intangible asset impairment charges |
GoodwillAndIntangibleAssetImpairment
|
$210.23M | USD | Annual |
| Debt redemption and refinancing charges |
DebtRefinancingCharge
|
$97.55M | USD | Annual |
| Debt redemption and refinancing charges |
DebtRefinancingCharge
|
$48.07M | USD | Annual |
| Stock-based compensation expense |
ShareBasedCompensation
|
$60.00M | USD | Annual |
| Stock-based compensation expense |
ShareBasedCompensation
|
$56.66M | USD | Annual |
| Stock-based compensation expense |
ShareBasedCompensation
|
$56.74M | USD | Annual |
| Tax benefits from stock award exercises |
EmployeeServiceStockBasedCompensationTaxBenefitFromCompensationExpense
|
$46.90M | USD | Annual |
| Tax benefits from stock award exercises |
EmployeeServiceStockBasedCompensationTaxBenefitFromCompensationExpense
|
$59.12M | USD | Annual |
| Tax benefits from stock award exercises |
EmployeeServiceStockBasedCompensationTaxBenefitFromCompensationExpense
|
$45.75M | USD | Annual |
| Excess tax benefits from stock award exercises |
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
|
$36.20M | USD | Annual |
| Excess tax benefits from stock award exercises |
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
|
$45.27M | USD | Annual |
| Excess tax benefits from stock award exercises |
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
|
$28.16M | USD | Annual |
| Deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
$-25.38M | USD | Annual |
| Deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
$61.74M | USD | Annual |
| Deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
$210.96M | USD | Annual |
| Equity investment income, net |
AdjustmentIncomeLossFromEquityMethodInvestments
|
$-10.12M | USD | Annual |
| Equity investment income, net |
AdjustmentIncomeLossFromEquityMethodInvestments
|
$-9.29M | USD | Annual |
| Equity investment income, net |
AdjustmentIncomeLossFromEquityMethodInvestments
|
$-2.87M | USD | Annual |
| Other non-cash charges |
OtherNoncashIncomeExpense
|
$-39.27M | USD | Annual |
| Other non-cash charges |
OtherNoncashIncomeExpense
|
$31.35M | USD | Annual |
| Other non-cash charges |
OtherNoncashIncomeExpense
|
$-44.69M | USD | Annual |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$59.64M | USD | Annual |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$40.68M | USD | Annual |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$202.87M | USD | Annual |
| Inventories |
IncreaseDecreaseInInventories
|
$8.97M | USD | Annual |
| Inventories |
IncreaseDecreaseInInventories
|
$46.40M | USD | Annual |
| Inventories |
IncreaseDecreaseInInventories
|
$48.31M | USD | Annual |
| Other receivables and other current assets |
IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets
|
$108.43M | USD | Annual |
| Other receivables and other current assets |
IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets
|
$61.67M | USD | Annual |
| Other receivables and other current assets |
IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets
|
$-32.76M | USD | Annual |
| Other long-term assets |
IncreaseDecreaseInOtherNoncurrentAssets
|
$-2.92M | USD | Annual |
| Other long-term assets |
IncreaseDecreaseInOtherNoncurrentAssets
|
$-3.72M | USD | Annual |
| Other long-term assets |
IncreaseDecreaseInOtherNoncurrentAssets
|
$-17.73M | USD | Annual |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$16.67M | USD | Annual |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$31.00M | USD | Annual |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$-2.96M | USD | Annual |
| Accrued compensation and benefits |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$54.95M | USD | Annual |
| Accrued compensation and benefits |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$38.37M | USD | Annual |
| Accrued compensation and benefits |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$97.26M | USD | Annual |
| Other current liabilities |
IncreaseDecreaseInOtherCurrentLiabilities
|
$83.59M | USD | Annual |
| Other current liabilities |
IncreaseDecreaseInOtherCurrentLiabilities
|
$78.82M | USD | Annual |
| Other current liabilities |
IncreaseDecreaseInOtherCurrentLiabilities
|
$113.47M | USD | Annual |
| Settlement payments |
IncreaseDecreaseInLossContingencyPayments
|
$-493.77M | USD | Annual |
| Settlement payments |
IncreaseDecreaseInLossContingencyPayments
|
$-410.36M | USD | Annual |
| Income taxes |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$33.50M | USD | Annual |
| Income taxes |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$-60.48M | USD | Annual |
| Income taxes |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$24.18M | USD | Annual |
| Other long-term liabilities |
IncreaseDecreaseInOtherNoncurrentLiabilities
|
$33.35M | USD | Annual |
| Other long-term liabilities |
IncreaseDecreaseInOtherNoncurrentLiabilities
|
$-1.58M | USD | Annual |
| Other long-term liabilities |
IncreaseDecreaseInOtherNoncurrentLiabilities
|
$66.14M | USD | Annual |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
$1.46B | USD | Annual |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
$1.77B | USD | Annual |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
$1.56B | USD | Annual |
| Additions of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$641.33M | USD | Annual |
| Additions of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$708.00M | USD | Annual |
| Additions of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$617.60M | USD | Annual |
| Acquisitions |
PaymentsToAcquireBusinessesGross
|
$272.09M | USD | Annual |
| Acquisitions |
PaymentsToAcquireBusinessesGross
|
$96.47M | USD | Annual |
| Acquisitions |
PaymentsToAcquireBusinessesGross
|
$310.39M | USD | Annual |
| Proceeds from asset and business sales |
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
|
$19.71M | USD | Annual |
| Proceeds from asset and business sales |
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
|
$62.26M | USD | Annual |
| Proceeds from asset and business sales |
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
|
$8.79M | USD | Annual |
| Purchase of investments available-for-sale |
PaymentsToAcquireAvailableForSaleSecurities
|
$8.44M | USD | Annual |
| Purchase of investments available-for-sale |
PaymentsToAcquireAvailableForSaleSecurities
|
$8.78M | USD | Annual |
| Purchase of investments available-for-sale |
PaymentsToAcquireAvailableForSaleSecurities
|
$12.45M | USD | Annual |
| Purchase of investments held-to-maturity |
PaymentsToAcquireHeldToMaturitySecurities
|
$472.63M | USD | Annual |
| Purchase of investments held-to-maturity |
PaymentsToAcquireHeldToMaturitySecurities
|
$1.04M | USD | Annual |
| Purchase of investments held-to-maturity |
PaymentsToAcquireHeldToMaturitySecurities
|
$1.71B | USD | Annual |
| Proceeds from sale of investments available-for-sale |
ProceedsFromSaleOfAvailableForSaleSecurities
|
$2.06M | USD | Annual |
| Proceeds from sale of investments available-for-sale |
ProceedsFromSaleOfAvailableForSaleSecurities
|
$2.48M | USD | Annual |
| Proceeds from sale of investments available-for-sale |
ProceedsFromSaleOfAvailableForSaleSecurities
|
$4.16M | USD | Annual |
| Proceeds from investments held-to-maturity |
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
|
$1.64B | USD | Annual |
| Proceeds from investments held-to-maturity |
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
|
$1.38M | USD | Annual |
| Proceeds from investments held-to-maturity |
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
|
$141.07M | USD | Annual |
| Purchase of intangible assets |
PaymentsToAcquireIntangibleAssets
|
$2.39M | USD | Annual |
| Purchase of intangible assets |
PaymentsToAcquireIntangibleAssets
|
$1.02M | USD | Annual |
| Purchase of equity investments |
PaymentsToAcquireEquityMethodInvestments
|
$17.91M | USD | Annual |
| Purchase of equity investments |
PaymentsToAcquireEquityMethodInvestments
|
$1.30M | USD | Annual |
| Purchase of equity investments |
PaymentsToAcquireEquityMethodInvestments
|
$35.38M | USD | Annual |
| Distributions received on equity investments |
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
|
$129.00K | USD | Annual |
| Distributions received on equity investments |
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
|
$497.00K | USD | Annual |
| Distributions received on equity investments |
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
|
$825.00K | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
$-881.78M | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
$-1.28B | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
$-876.88M | USD | Annual |
| Borrowings |
ProceedsFromIssuanceOfLongTermDebt
|
$60.04B | USD | Annual |
| Borrowings |
ProceedsFromIssuanceOfLongTermDebt
|
$66.29B | USD | Annual |
| Borrowings |
ProceedsFromIssuanceOfLongTermDebt
|
$54.54B | USD | Annual |
| Payments on long-term debt and other financing costs |
RepaymentsOfDebtAndCapitalLeaseObligations
|
$60.05B | USD | Annual |
| Payments on long-term debt and other financing costs |
RepaymentsOfDebtAndCapitalLeaseObligations
|
$53.92B | USD | Annual |
| Payments on long-term debt and other financing costs |
RepaymentsOfDebtAndCapitalLeaseObligations
|
$66.72B | USD | Annual |
| Deferred financing and debt redemption and refinancing costs |
PaymentsOfFinancingCosts
|
$76.67M | USD | Annual |
| Deferred financing and debt redemption and refinancing costs |
PaymentsOfFinancingCosts
|
$122.99M | USD | Annual |
| Deferred financing and debt redemption and refinancing costs |
PaymentsOfFinancingCosts
|
$719.00K | USD | Annual |
| Purchase of treasury stock |
PaymentsForRepurchaseOfCommonStock
|
$549.93M | USD | Annual |
| Distributions to noncontrolling interests |
PaymentsOfDistributionsToAffiliates
|
$149.34M | USD | Annual |
| Distributions to noncontrolling interests |
PaymentsOfDistributionsToAffiliates
|
$139.33M | USD | Annual |
| Distributions to noncontrolling interests |
PaymentsOfDistributionsToAffiliates
|
$174.63M | USD | Annual |
| Stock award exercises and other share issuances, net |
ProceedsFromStockOptionsExercised
|
$26.16M | USD | Annual |
| Stock award exercises and other share issuances, net |
ProceedsFromStockOptionsExercised
|
$16.42M | USD | Annual |
| Stock award exercises and other share issuances, net |
ProceedsFromStockOptionsExercised
|
$19.50M | USD | Annual |
| Excess tax benefits from stock award exercises |
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
$45.27M | USD | Annual |
| Excess tax benefits from stock award exercises |
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
$28.16M | USD | Annual |
| Excess tax benefits from stock award exercises |
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
$36.20M | USD | Annual |
| Contributions from noncontrolling interests |
ProceedsFromContributionsFromAffiliates
|
$64.66M | USD | Annual |
| Contributions from noncontrolling interests |
ProceedsFromContributionsFromAffiliates
|
$54.64M | USD | Annual |
| Contributions from noncontrolling interests |
ProceedsFromContributionsFromAffiliates
|
$37.00M | USD | Annual |
| Proceeds from sales of additional noncontrolling interests |
ProceedsFromMinorityShareholders
|
$3.78M | USD | Annual |
| Proceeds from sales of additional noncontrolling interests |
ProceedsFromMinorityShareholders
|
$8.29M | USD | Annual |
| Purchases of noncontrolling interests |
PaymentsToMinorityShareholders
|
$3.57M | USD | Annual |
| Purchases of noncontrolling interests |
PaymentsToMinorityShareholders
|
$66.38M | USD | Annual |
| Purchases of noncontrolling interests |
PaymentsToMinorityShareholders
|
$17.88M | USD | Annual |
| Net cash used in financing activities |
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
$-482.99M | USD | Annual |
| Net cash used in financing activities |
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
$-164.98M | USD | Annual |
| Net cash used in financing activities |
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
$-138.97M | USD | Annual |
| Effect of exchange rate changes on cash and cash equivalents |
EffectOfExchangeRateOnCashAndCashEquivalents
|
$-967.00K | USD | Annual |
| Effect of exchange rate changes on cash and cash equivalents |
EffectOfExchangeRateOnCashAndCashEquivalents
|
$-2.57M | USD | Annual |
| Effect of exchange rate changes on cash and cash equivalents |
EffectOfExchangeRateOnCashAndCashEquivalents
|
$2.29M | USD | Annual |
| Net increase in cash and cash equivalents |
CashAndCashEquivalentsPeriodIncreaseDecrease
|
$18.99M | USD | Annual |
| Net increase in cash and cash equivalents |
CashAndCashEquivalentsPeriodIncreaseDecrease
|
$533.88M | USD | Annual |
| Net increase in cash and cash equivalents |
CashAndCashEquivalentsPeriodIncreaseDecrease
|
$412.50M | USD | Annual |
| Cash and cash equivalents at beginning of the year |
CashAndCashEquivalentsAtCarryingValue
|
$946.25M | USD | Point-in-time |
| Cash and cash equivalents at beginning of the year |
CashAndCashEquivalentsAtCarryingValue
|
$1.50B | USD | Point-in-time |
| Cash and cash equivalents at beginning of the year |
CashAndCashEquivalentsAtCarryingValue
|
$965.24M | USD | Point-in-time |
| Cash and cash equivalents at beginning of the year |
CashAndCashEquivalentsAtCarryingValue
|
$533.75M | USD | Point-in-time |
| Cash and cash equivalents at end of the year |
CashAndCashEquivalentsAtCarryingValue
|
$946.25M | USD | Point-in-time |
| Cash and cash equivalents at end of the year |
CashAndCashEquivalentsAtCarryingValue
|
$1.50B | USD | Point-in-time |
| Cash and cash equivalents at end of the year |
CashAndCashEquivalentsAtCarryingValue
|
$965.24M | USD | Point-in-time |
| Cash and cash equivalents at end of the year |
CashAndCashEquivalentsAtCarryingValue
|
$533.75M | USD | Point-in-time |
Stockholders Equity
15 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Beginning Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.08B | USD | Point-in-time |
| Beginning Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.36B | USD | Point-in-time |
| Beginning Balance (in shares) |
CommonStockSharesOutstanding
|
209.75M | shares | Point-in-time |
| Beginning Balance (in shares) |
CommonStockSharesOutstanding
|
215.64M | shares | Point-in-time |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-22.37M | USD | Annual |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$12.65M | USD | Annual |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-34.81M | USD | Annual |
| Ending Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.08B | USD | Point-in-time |
| Ending Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.36B | USD | Point-in-time |
| Ending Balance (in shares) |
CommonStockSharesOutstanding
|
209.75M | shares | Point-in-time |
| Ending Balance (in shares) |
CommonStockSharesOutstanding
|
215.64M | shares | Point-in-time |
| Purchase of treasury stock |
TreasuryStockValueAcquiredCostMethod
|
$575.38M | USD | Annual |
| Purchase of treasury stock (in shares) |
TreasuryStockSharesAcquired
|
0.00 | shares | Annual |
| Purchase of treasury stock (in shares) |
TreasuryStockSharesAcquired
|
7.78M | shares | Annual |
| Purchase of treasury stock (in shares) |
TreasuryStockSharesAcquired
|
0.00 | shares | Annual |
Comprehensive Income
30 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income |
ProfitLoss
|
$863.33M | USD | Annual |
| Net income |
ProfitLoss
|
$427.41M | USD | Annual |
| Net income |
ProfitLoss
|
$757.20M | USD | Annual |
| Unrealized (losses) gain on interest rate swap and cap agreements |
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
$169.00K | USD | Annual |
| Unrealized (losses) gain on interest rate swap and cap agreements |
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
$-12.24M | USD | Annual |
| Unrealized (losses) gain on interest rate swap and cap agreements |
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
$-10.06M | USD | Annual |
| Reclassifications of net swap and cap agreements realized losses into net income |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
|
$-3.11M | USD | Annual |
| Reclassifications of net swap and cap agreements realized losses into net income |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
|
$-12.89M | USD | Annual |
| Reclassifications of net swap and cap agreements realized losses into net income |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
|
$-10.61M | USD | Annual |
| Unrealized (losses) gains on investments |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$238.00K | USD | Annual |
| Unrealized (losses) gains on investments |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$2.30M | USD | Annual |
| Unrealized (losses) gains on investments |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-1.41M | USD | Annual |
| Reclassification of net investment realized losses into net income |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
$207.00K | USD | Annual |
| Reclassification of net investment realized losses into net income |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
$490.00K | USD | Annual |
| Reclassification of net investment realized losses into net income |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
|
$377.00K | USD | Annual |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-22.95M | USD | Annual |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-23.89M | USD | Annual |
| Foreign currency translation adjustments |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-2.22M | USD | Annual |
| Other comprehensive (loss) income |
OtherComprehensiveIncomeLossNetOfTax
|
$-22.37M | USD | Annual |
| Other comprehensive (loss) income |
OtherComprehensiveIncomeLossNetOfTax
|
$12.65M | USD | Annual |
| Other comprehensive (loss) income |
OtherComprehensiveIncomeLossNetOfTax
|
$-34.81M | USD | Annual |
| Total comprehensive income (losses) |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$840.96M | USD | Annual |
| Total comprehensive income (losses) |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$392.60M | USD | Annual |
| Total comprehensive income (losses) |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$769.85M | USD | Annual |
| Less: Comprehensive income attributable to noncontrolling interests |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$140.22M | USD | Annual |
| Less: Comprehensive income attributable to noncontrolling interests |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$123.75M | USD | Annual |
| Less: Comprehensive income attributable to noncontrolling interests |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$157.68M | USD | Annual |
| Comprehensive income attributable to DaVita HealthCare Partners Inc. |
ComprehensiveIncomeNetOfTax
|
$234.92M | USD | Annual |
| Comprehensive income attributable to DaVita HealthCare Partners Inc. |
ComprehensiveIncomeNetOfTax
|
$646.10M | USD | Annual |
| Comprehensive income attributable to DaVita HealthCare Partners Inc. |
ComprehensiveIncomeNetOfTax
|
$700.74M | USD | Annual |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.